Malaria vaccines: Identifying Plasmodium falciparum liver-stage targets

Frontiers in Microbiology

Volumn 6, Issue SEP, 2015, Pages

  Longley, Rhea J ^a,b,c,d   Hill, Adrian V S ^a   Spencer, Alexandra J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MAHIDOL UNIVERSITY   (Thailand)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Immunity; Liver stage; Malaria; T cells; Vaccine

Indexed keywords

EPITOPE; MALARIA VACCINE; TRANSCRIPTOME;

DEVELOPMENTAL STAGE; DRUG TARGETING; EXPERIMENTAL MODEL; GENE EXPRESSION PROFILING; GENOME; HUMAN; LIVER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALARIA FALCIPARUM; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; REVIEW; SPOROZOITE; T LYMPHOCYTE; UPREGULATION; VACCINATION;

EID: 84946712685     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00965     Document Type: Review

References (92)

1. Ashley, E. A., Dhorda, M., Fairhurst, R. M., Amaratunga, C., Lim, P., Suon, S., et al. (2014). Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371, 411-423. doi: 10.1056/NEJMoa1314981
2. Bauza, K., Malinauskas, T., Pfander, C., Anar, B., Jones, E. Y., Billker, O., et al. (2014). Efficacy of a Plasmodium vivax malaria vaccine using ChAd63 and modified vaccinia Ankara expressing thrombospondin-related anonymous protein as assessed with transgenic Plasmodium berghei parasites. Infect. Immun. 82, 1277-1286. doi: 10.1128/iai.01187-1113
3. Bijker, E. M., Bastiaens, G. J., Teirlinck, A. C., Van Gemert, G. J., Graumans, W., Van De Vegte-Bolmer, M., et al. (2013). Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. Proc. Natl. Acad. Sci. U.S.A. 110, 7862-7867. doi: 10.1073/pnas.1220360110
4. Brahimi, K., Badell, E., Sauzet, J. P., Benmohamed, L., Daubersies, P., Guerin-Marchand, C., et al. (2001). Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo. Infect. Immun. 69, 3845-3852. doi: 10.1128/iai.69.6.3845-3952.2001
5. Cao, Y., Zhang, D., and Pan, W. (2009). Construction of transgenic Plasmodium berghei as a model for evaluation of blood-stage vaccine candidate of Plasmodium falciparum chimeric protein 2.9. PLoS ONE 4:e6894. doi: 10.1371/journal.pone.0006894
6. Clyde, D. F., Most, H., Mccarthy, V. C., and Vanderberg, J. P. (1973). Immunization of man against sporozite-induced falciparum malaria. Am. J. Med. Sci. 266, 169-177. doi: 10.1097/00000441-197309000-00002
7. Deal, C., Balazs, A. B., Espinosa, D. A., Zavala, F., Baltimore, D., and Ketner, G. (2014). Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice. Proc. Natl. Acad. Sci. U.S.A. 111, 12528-12532. doi: 10.1073/pnas.1407362111
8. Dembele, L., Franetich, J. F., Lorthiois, A., Gego, A., Zeeman, A. M., Kocken, C. H., et al. (2014). Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures. Nat. Med. 20, 307-312. doi: 10.1038/nm.3461
9. Doolan, D. L. (2011). Plasmodium immunomics. Int. J. Parasitol. 41, 3-20. doi: 10.1016/j.ijpara.2010.08.002
10. Doolan, D. L., Sedegah, M., Hedstrom, R. C., Hobart, P., Charoenvit, Y., and Hoffman, S. L. (1996). Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 183, 1739-1746. doi: 10.1084/jem.183.4.1739
11. Doolan, D. L., Southwood, S., Freilich, D. A., Sidney, J., Graber, N. L., Shatney, L., et al. (2003). Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl. Acad. Sci. U.S.A. 100, 9952-9957. doi: 10.1073/pnas.1633254100
12. Drew, D. R., and Beeson, J. G. (2015). PfRH5 as a candidate vaccine for Plasmodium falciparum malaria. Trends Parasitol. 31, 87-88. doi: 10.1016/j.pt.2015.02.001
13. Dumoulin, P. C., Trop, S. A., Ma, J., Zhang, H., Sherman, M. A., and Levitskaya, J. (2015). Flow cytometry based detection and isolation of Plasmodium falciparum liver stages in vitro. PLoS ONE 10:e0129623. doi: 10.1371/journal.pone.0129623
14. Espinosa, D. A., Yadava, A., Angov, E., Maurizio, P. L., Ockenhouse, C. F., and Zavala, F. (2013). Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy. Infect. Immun. 81, 2882-2887. doi: 10.1128/iai.00461-413
15. Ewer, K. J., O'hara, G. A., Duncan, C. J., Collins, K. A., Sheehy, S. H., Reyes-Sandoval, A., et al. (2013). Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation. Nat. Commun. 4, 2836. doi: 10.1038/ncomms3836
16. Fidock, D. A., Pasquetto, V., Gras, H., Badell, E., Eling, W., Ballou, W. R., et al. (1997). Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen. Eur. J. Immunol. 27, 2502-2513. doi: 10.1002/eji.1830271007
17. Finney, O. C., Keitany, G. J., Smithers, H., Kaushansky, A., Kappe, S., and Wang, R. (2014). Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites. Vaccine 32, 2135-2138. doi: 10.1016/j.vaccine.2014.02.055
18. Florens, L., Washburn, M. P., Raine, J. D., Anthony, R. M., Grainger, M., Haynes, J. D., et al. (2002). A proteomic view of the Plasmodium falciparum life cycle. Nature 419, 520-526. doi: 10.1038/nature01107
19. Flyer, D. C., Ramakrishna, V., Miller, C., Myers, H., Mcdaniel, M., Root, K., et al. (2002). Identification by mass spectrometry of CD8+-T-cell Mycobacterium tuberculosis epitopes within the Rv0341 gene product. Infect. Immun. 70, 2926-2932. doi: 10.1128/IAI.70.6.2926-2932.2002
20. Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., et al. (2002). Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498-511. doi: 10.1038/nature01097
21. Gaucher, D., Therrien, R., Kettaf, N., Angermann, B. R., Boucher, G., Filali-Mouhim, A., et al. (2008). Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205, 3119-3131. doi: 10.1084/jem.20082292
22. Gilbert, S. C., Plebanski, M., Harris, S. J., Allsopp, C. E., Thomas, R., Layton, G. T., et al. (1997). A protein particle vaccine containing multiple malaria epitopes. Nat. Biotechnol. 15, 1280-1284. doi: 10.1038/nbt1197-1280
23. Greenwood, B. M. (2015). Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31-45. doi: 10.1016/s0140-6736(15)60721-60728
24. Gwadz, R. W., Cochrane, A. H., Nussenzweig, V., and Nussenzweig, R. S. (1979). Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull. World Health Organ. 57(Suppl. 1), 165-173.
25. Hoffman, S. L., Isenbarger, D., Long, G. W., Sedegah, M., Szarfman, A., Waters, L., et al. (1989). Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244, 1078-1081. doi: 10.1126/science.2524877
26. Hollingdale, M. R., Appiah, A., Leland, P., Do Rosario, V. E., Mazier, D., Pied, S., et al. (1990). Activity of human volunteer sera to candidate Plasmodium falciparum circumsporozoite protein vaccines in the inhibition of sporozoite invasion assay of human hepatoma cells and hepatocytes. Trans. R. Soc. Trop. Med. Hyg. 84, 325-329. doi: 10.1016/0035-9203(90)90303-V
27. Hollingdale, M. R., Ballou, W. R., Aley, S. B., Young, J. F., Pancake, S., Miller, L. H., et al. (1987). Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells. Exp. Parasitol. 63, 345-351. doi: 10.1016/0014-4894(87)90182-2
28. House, B. L., Hollingdale, M. R., Sacci, J. B. Jr., and Richie, T. L. (2009). Functional immunoassays using an in-vitro malaria liver-stage infection model: where do we go from here? Trends Parasitol. 25, 525-533. doi: 10.1016/j.pt.2009.08.004
29. Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., et al. (1992). Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255, 1261-1263. doi: 10.1126/science.1546328
30. Janse, C. J., Franke-Fayard, B., Mair, G. R., Ramesar, J., Thiel, C., Engelmann, S., et al. (2006). High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. Mol. Biochem. Parasitol. 145, 60-70. doi: 10.1016/j.molbiopara.2005.09.007
31. Jeffery, G. M., Wolcott, G. B., Young, M. D., and Williams, D. Jr. (1952). Exo-erythrocytic stages of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 1, 917-925.
32. Karnasuta, C., Pavanand, K., Chantakulkij, S., Luttiwongsakorn, N., Rassamesoraj, M., Laohathai, K., et al. (1995). Complete development of the liver stage of Plasmodium falciparum in a human hepatoma cell line. Am. J. Trop. Med. Hyg. 53, 607-611.
33. Kumar, K. A., Sano, G., Boscardin, S., Nussenzweig, R. S., Nussenzweig, M. C., Zavala, F., et al. (2006). The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444, 937-940. doi: 10.1038/nature05361
34. Lau, A. O., Sacci, J. B. Jr., and Azad, A. F. (2001). Detection of Plasmodium yoelii stage mRNA in BALB/c mice. J. Parasitol. 87, 19-23. doi: 10.1645/0022-3395(2001)087[0019:dopysm]2.0.co;2
35. Li, A. P. (2014). In vitro human hepatocyte-based experimental systems for the evaluation of human drug metabolism, drug-drug interactions, and drug toxicity in drug development. Curr. Top. Med. Chem. 14, 1325-1338. doi: 10.2174/1568026614666140506114411
36. Lin, J. W., Annoura, T., Sajid, M., Chevalley-Maurel, S., Ramesar, J., Klop, O., et al. (2011). A novel 'gene insertion/marker out' (GIMO) method for transgene expression and gene complementation in rodent malaria parasites. PLoS ONE 6:e29289. doi: 10.1371/journal.pone.0029289
37. Long, D., Skoberne, M., Gierahn, T. M., Larson, S., Price, J. A., Clemens, V., et al. (2014). Identification of novel virus-specific antigens by CD4+ and CD8+ T cells from asymptomatic HSV-2 seropositive and seronegative donors. Virology 464-465, 296-311. doi: 10.1016/j.virol.2014.07.018
38. Longley, R. J., Bauza, K., Ewer, K. J., Hill, A. V., and Spencer, A. J. (2015a). Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells. PLoS ONE 10:e0119880. doi: 10.1371/journal.pone.0119880
39. Longley, R. J., Salman, A. M., Cottingham, M. G., Ewer, K., Janse, C. J., Khan, S. M., et al. (2015b). Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates. Sci. Rep. 5, 11820. doi: 10.1038/srep11820
40. March, S., Ng, S., Velmurugan, S., Galstian, A., Shan, J., Logan, D. J., et al. (2013). A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe 14, 104-115. doi: 10.1016/j.chom.2013.06.005
41. Mazier, D., Beaudoin, R. L., Mellouk, S., Druilhe, P., Texier, B., Trosper, J., et al. (1985). Complete development of hepatic stages of Plasmodium falciparum in vitro. Science 227, 440-442. doi: 10.1126/science.3880923
42. Mazier, D., Mellouk, S., Beaudoin, R. L., Texier, B., Druilhe, P., Hockmeyer, W., et al. (1986). Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro. Science 231, 156-159. doi: 10.1126/science.3510455
43. McConkey, S. J., Reece, W. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, G., et al. (2003). Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat. Med. 9, 729-735. doi: 10.1038/nm881
44. Mellouk, S., Berbiguier, N., Druilhe, P., Sedegah, M., Galey, B., Yuan, L., et al. (1990). Evaluation of an in vitro assay aimed at measuring protective antibodies against sporozoites. Bull. World Health Organ. 68(Suppl.), 52-59.
45. Mikolajczak, S. A., Sacci, J. B. Jr., De La Vega, P., Camargo, N., Vanbuskirk, K., Krzych, U., et al. (2011). Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites. Cell Microbiol. 13, 1250-1260. doi: 10.1111/j.1462-5822.2011.01617.x
46. Mikolajczak, S. A., Vaughan, A. M., Kangwanrangsan, N., Roobsoong, W., Fishbaugher, M., Yimamnuaychok, N., et al. (2015). Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe 17, 526-535. doi: 10.1016/j.chom.2015.02.011
47. Mizutani, M., Iyori, M., Blagborough, A. M., Fukumoto, S., Funatsu, T., Sinden, R. E., et al. (2014). Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites. Infect. Immun. 82, 4348-4357. doi: 10.1128/iai.02040-2014
48. Mlambo, G., Maciel, J., and Kumar, N. (2008). Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25. Infect. Immun. 76, 2018-2024. doi: 10.1128/iai.01409-1407
49. Morosan, S., Hez-Deroubaix, S., Lunel, F., Renia, L., Giannini, C., Van Rooijen, N., et al. (2006). Liver-stage development of Plasmodium falciparum, in a humanized mouse model. J. Infect. Dis. 193, 996-1004. doi: 10.1086/500840
50. Nardin, E. H., Nussenzweig, V., Nussenzweig, R. S., Collins, W. E., Harinasuta, K. T., Tapchaisri, P., et al. (1982). Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J. Exp. Med. 156, 20-30. doi: 10.1084/jem.156.1.20
51. Ng, S., March, S., Galstian, A., Hanson, K., Carvalho, T., Mota, M. M., et al. (2014). Hypoxia promotes liver-stage malaria infection in primary human hepatocytes in vitro. Dis. Model. Mech. 7, 215-224. doi: 10.1242/dmm.013490
52. Nussenzweig, R. S., Vanderberg, J., Most, H., and Orton, C. (1967). Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216, 160-162. doi: 10.1038/216160a0
53. Nussenzweig, V., and Nussenzweig, R. S. (1985). Circumsporozoite proteins of malaria parasites. Cell 42, 401-403. doi: 10.1016/0092-8674(85)90093-5
54. Offeddu, V., Thathy, V., Marsh, K., and Matuschewski, K. (2012). Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection. Int. J. Parasitol. 42, 535-548. doi: 10.1016/j.ijpara.2012.03.011
55. Ogwang, C., Kimani, D., Edwards, N. J., Roberts, R., Mwacharo, J., Bowyer, G., et al. (2015). Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults. Sci Trans. Med. 7, 286re285. doi: 10.1126/scitranslmed.aaa2373
56. Persson, C., Oliveira, G. A., Sultan, A. A., Bhanot, P., Nussenzweig, V., and Nardin, E. (2002). Cutting edge: a new tool to evaluate human pre-erythrocytic malaria vaccines: rodent parasites bearing a hybrid Plasmodium falciparum circumsporozoite protein. J. Immunol. 169, 6681-6685. doi: 10.4049/jimmunol.169.12.6681
57. Porter, M. D., Nicki, J., Pool, C. D., Debot, M., Illam, R. M., Brando, C., et al. (2013). Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint. Clin. Vaccine Immunol. 20, 803-810. doi: 10.1128/cvi.00066-13
58. Ramakrishna, V., Ross, M. M., Petersson, M., Gatlin, C. C., Lyons, C. E., Miller, C. L., et al. (2003). Naturally occurring peptides associated with HLA-A2 in ovarian cancer cell lines identified by mass spectrometry are targets of HLA-A2-restricted cytotoxic T cells. Int. Immunol. 15, 751-763. doi: 10.1093/intimm/dxg074
59. Ranson, H., N'guessan, R., Lines, J., Moiroux, N., Nkuni, Z., and Corbel, V. (2011). Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol. 27, 91-98. doi: 10.1016/j.pt.2010.08.004
60. Renia, L., Grillot, D., Marussig, M., Corradin, G., Miltgen, F., Lambert, P. H., et al. (1993). Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150, 1471-1478.
61. Renia, L., Marussig, M. S., Grillot, D., Pied, S., Corradin, G., Miltgen, F., et al. (1991). In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. Proc. Natl. Acad. Sci. U.S.A. 88, 7963-7967. doi: 10.1073/pnas.88.18.7963
62. Rieckmann, K. H., Carson, P. E., Beaudoin, R. L., Cassells, J. S., and Sell, K. W. (1974). Letter: sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans. R. Soc. Trop Med. Hyg. 68, 258-259. doi: 10.1016/0035-9203(74)90129-1
63. Roestenberg, M., Teirlinck, A. C., Mccall, M. B., Teelen, K., Makamdop, K. N., Wiersma, J., et al. (2011). Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377, 1770-1776. doi: 10.1016/s0140-6736(11)60360-60367
64. Russell, P. F., and Mohan, B. N. (1942). The immunization of fowls against mosquito-borne Plasmodium gallinaceum by injections of serum and of inactivated homologous sporozoites. J. Exp. Med. 76, 477-495. doi: 10.1084/jem.76.5.477
65. Sacci, J. B. Jr., Alam, U., Douglas, D., Lewis, J., Tyrrell, D. L., Azad, A.F., et al. (2006). Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers. Int. J. Parasitol. 36, 353-360. doi: 10.1016/j.ijpara.2005.10.014
66. Sacci, J. B. Jr., Ribeiro, J. M., Huang, F., Alam, U., Russell, J. A., Blairet, P. L., et al. (2005). Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression. Mol. Biochem. Parasitol. 142, 177-183. doi: 10.1016/j.molbiopara.2005.03.018
67. Sattabongkot, J., Yimamnuaychoke, N., Leelaudomlipi, S., Rasameesoraj, M., Jenwithisuk, R., Coleman, R. E., et al. (2006). Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am. J. Trop. Med. Hyg. 74, 708-715.
68. Schofield, L., Villaquiran, J., Ferreira, A., Schellekens, H., Nussenzweig, R., and Nussenzweig, V. (1987). Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330, 664-666. doi: 10.1038/330664a0
69. Schwenk, R., Debot, M., Porter, M., Nikki, J., Rein, L., Spaccapelo, R., et al. (2014). IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice. PLoS ONE 9:e111020. doi: 10.1371/journal.pone.0111020
70. Seder, R. A., Chang, L. J., Enama, M. E., Zephir, K. L., Sarwar, U. N., Gordon, I. J., et al. (2013). Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341, 1359-1365. doi: 10.1126/science.1241800
71. Seguin, M. C., Klotz, F. W., Schneider, I., Weir, J. P., Goodbary, M., Slayter, M., et al. (1994). Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J. Exp. Med. 180, 353-358. doi: 10.1084/jem.180.1.353
72. Sheehy, S. H., Spencer, A. J., Douglas, A. D., Sim, B. K., Longley, R. J., Edwards, N. J., et al. (2013). Optimising controlled human malaria infection studies using cryopreserved parasites administered by needle and syringe. PLoS ONE 8:e65960. doi: 10.1371/journal.pone.0065960
73. Shortt, H. E., Fairley, N. H., Covell, G., Shute, P. G., and Garnham, P. C. (1951). The pre-erythrocytic stage of Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 44, 405-419. doi: 10.1016/S0035-9203(51)80019-1
74. Siau, A., Silvie, O., Franetich, J. F., Yalaoui, S., Marinach, C., Hannoun, L., et al. (2008). Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection. PLoS Pathog. 4:e1000121. doi: 10.1371/journal.ppat.1000121
75. Talman, A. M., Blagborough, A. M., and Sinden, R. E. (2010). A Plasmodium falciparum strain expressing GFP throughout the parasite's life-cycle. PLoS ONE 5:e9156. doi: 10.1371/journal.pone.0009156
76. Tarun, A. S., Peng, X., Dumpit, R. F., Ogata, Y., Silva-Rivera, H., Camargo, N., et al. (2008). A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl. Acad. Sci. U.S.A. 105, 305-310. doi: 10.1073/pnas.0710780104
77. Testa, J. S., Shetty, V., Hafner, J., Nickens, Z., Kamal, S., Sinnathamby, G., et al. (2012). MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. PLoS ONE 7:e48484. doi: 10.1371/journal.pone.0048484
78. Trieu, A., Kayala, M. A., Burk, C., Molina, D. M., Freilich, D. A., Richie, T. L., et al. (2011). Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol. Cell Proteomics 10, M111007948. doi: 10.1074/mcp.M111.007948
79. Trimnell, A., Takagi, A., Gupta, M., Richie, T. L., Kappe, S. H., and Wang, R. (2009). Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. J. Immunol. 183, 5870-5878. doi: 10.4049/jimmunol.0900302
80. Trolle, T., Metushi, I. G., Greenbaum, J. A., Kim, Y., Sidney, J., Lund, O., et al. (2015). Automated benchmarking of peptide-MHC class I binding predictions. Bioinformatics 31, 2174-2181. doi: 10.1093/bioinformatics/btv123
81. van Dijk, M. R., Van Schaijk, B. C., Khan, S. M., Van Dooren, M. W., Ramesar, J., Kaczanowski, S., et al. (2010). Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility. PLoS Pathog 6:e1000853. doi: 10.1371/journal.ppat.1000853
82. Vaughan, A. M., Mikolajczak, S. A., Camargo, N., Lakshmanan, V., Kennedy, M., Lindner, S. E., et al. (2012a). A transgenic Plasmodium falciparum NF54 strain that expresses GFP-luciferase throughout the parasite life cycle. Mol. Biochem. Parasitol. 186, 143-147. doi: 10.1016/j.molbiopara.2012.10.004
83. Vaughan, A. M., Mikolajczak, S. A., Wilson, E. M., Grompe, M., Kaushansky, A., Camargo, N., et al. (2012b). Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J. Clin. Invest. 122, 3618-3628. doi: 10.1172/jci62684
84. Wang, Q., Brown, S., Roos, D. S., Nussenzweig, V., and Bhanot, P. (2004). Transcriptome of axenic liver stages of Plasmodium yoelii. Mol. Biochem. Parasitol. 137, 161-168. doi: 10.1016/j.molbiopara.2004.06.001
85. Weiss, W. R., and Jiang, C. G. (2012). Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PLoS ONE 7:e31247. doi: 10.1371/journal.pone.0031247
86. Weiss, W. R., Mellouk, S., Houghten, R. A., Sedegah, M., Kumar, S., Good, M. F., et al. (1990). Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 171, 763-773. doi: 10.1084/jem.171.3.763
87. Weiss, W. R., Sedegah, M., Beaudoin, R. L., Miller, L. H., and Good, M. F. (1988). CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. U.S.A. 85, 573-576. doi: 10.1073/pnas.85.2.573
88. WHO. (2014). World Malaria Report 2013. (Geneva: World Health Organization).
89. Wolk, B., Trautwein, C., Buchele, B., Kersting, N., Blum, H. E., Rammensee, H. G., et al. (2012). Identification of naturally processed hepatitis C virus-derived major histocompatibility complex class I ligands. PLoS ONE 7:e29286. doi: 10.1371/journal.pone.0029286
90. Yoshida, N., Nussenzweig, R. S., Potocnjak, P., Nussenzweig, V., and Aikawa, M. (1980). Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 207, 71-73. doi: 10.1126/science.6985745
91. Zhong, W., Reche, P. A., Lai, C. C., Reinhold, B., and Reinherz, E. L. (2003). Genome-wide characterization of a viral cytotoxic T lymphocyte epitope repertoire. J. Biol. Chem. 278, 45135-45144. doi: 10.1074/jbc.M307417200
92. Zou, X., House, B. L., Zyzak, M. D., Richie, T. L., and Gerbasi, V. R. (2013). Towards an optimized inhibition of liver stage development assay (ILSDA) for Plasmodium falciparum. Malar. J. 12, 394. doi: 10.1186/1475-2875-12-394